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Pleural Empyema Due to Clostridium difficile and 
Clostridium cadaveris
Pleuropulmonary infections with clostridial species, usually 
Clostridium perfringens, have been reported occasionally [1]. We 
describe a patient with a bronchogenic cyst who developed pleuro­
pulmonary empyema due to Clostridium difficile and Clostridium 
cadaveris after surgical removal of the cyst.
A 33-year-old male pig farmer had had a bronchogenic cyst in 
the upper lobe of the left lung for ~8 years. Because the cyst was 
enlarging, segmental resection was performed on 31 January 1996. 
On the sixth postoperative day, the patient developed fever with 
leukocytosis (leukocyte count, 17,700 cells/mm3). A chest radio­
graph revealed pleural effusion on the left side. Foul-smelling fluid 
was obtained via transthoracic puncture on 11 February.
Culture of the material yielded two anaerobic gram-positive spore- 
forming rods with different colony morphologies and odors. With 
use of the API 20A system (bioMérieux, Marcy l’Etoile, France) and 
gas chromatography, the isolates were identified as C. difficile and 
C. cadaveris (the identity of the latter isolate was confirmed by Dr. 
M. McTeague, Wadsworth Anaerobe Laboratory, Los Angeles). The 
C. difficile strain produced cytotoxin B. The Etest (AB BIODISK, 
Solna, Sweden) showed that both organisms were susceptible to 
amoxicillin/clavulanate and metronidazole. Therapy with iv amoxicil-
lin/clavulanate (1,000/200 mg t.i.d.) was started on 11 February.
On 19 February, the patient developed a bronchopleural fistula. A 
second thoracotomy was performed on 21 February. The rest of the 
left lung was found to be necrotic, and pneumonectomy was per­
formed. Intravenous metronidazole (500 mg t.i.d.) was added to the 
patient’s regimen of amoxicillin/clavulanate. Cultures of fluid from 
the thoracic drain were repeatedly negative after antimicrobial therapy 
was initiated. The drain was removed on 1 March, antibiotic therapy 
was stopped, and the patient was discharged from the hospital.
Four days later, he returned to the hospital with fever and pain 
on the left side of the thorax. A chest radiograph revealed a normal 
pleural cavity but enlarged cardiac contours. An echocardiogram 
revealed a 5-cm pericardial effusion. A third thoracotomy with 
pericardiotomy was performed on 25 March for debridement fol­
lowed by drainage and daily rinsing with 5% povidone-iodine. 
Culture of the pleural fluid yielded only C. cadaveris; the isolate 
was susceptible in vitro to amoxicillin/clavulanate and metronida­
zole. The pericardial fluid was sterile. The patient again received
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the intravenous combination of amoxicillin/clavulanate (1,000/200 
mg q4h) and metronidazole (500 mg t.i.d.). Follow-up cultures of 
fluid from the drain were all sterile. Therapy with metronidazole 
was stopped on 12 April, and the drain was removed 1 week later. 
Therapy with amoxicillin/clavulanate was continued until 26 May 
(during the last 2 weeks, amoxicillin/clavulanate was administered 
orally at a dosage of 500/125 mg t.i.d.). A CT scan showed no 
signs of abscesses. The leukocyte count was 8,200/mm3. No 
/?-lactamase production was detected in the C. cadaveris isolate. 
The patient was discharged from the hospital in good clinical 
condition with a prescription for oral amoxicillin (500 mg q.i.d.). 
As of this writing (3 months later), he is clinically stable.
Few cases of pleural infection with C. difficile have been re­
ported [2, 3]. C. cadaveris is not known to produce a toxin and is 
considered to be nonpathogenic for humans and laboratory animals 
[4]. However, C. cadaveris bacteremia (in two immunocomprom­
ised patients) and C. cadaveris-associated spontaneous bacterial 
peritonitis have been described [5, 6]. Aspiration of aerosol from 
animal material while handling dead piglets seems to be a logical 
explanation for our patient’s pulmonary infection. The severity of 
his infection with two anaerobic organisms that are both considered 
to be of little pathogenic importance, with destruction of a whole 
lung despite adequate antimicrobial therapy, is remarkable.
We believe that the C. cadaveris isolate persisted after 4 weeks 
of therapy because of its capacity to sporulate. The persistence of 
C. cadaveris despite adequate therapy was not described in the 
three previously mentioned case reports [5, 6]; those patients all 
died of complications during hospitalization, which obscured the 
possible role of C. cadaveris. We conclude that the pathogenicity 
of C. cadaveris needs further study.
Virginia Stolk-Engelaar, Jeroen Verwiel, Ger Bongaerts,
Vic Linsen, Leon Lacquet, and Anton Cox
Department o f  M edical Microbiology’, University Hospital Nijmegen; 
and University Lungcentre Dekkerswald, Nijmegen, the Netherlands
References
1. Bekemeyer WB, Clostridial infections of the lungs and pleura. South Med
J 1986;79:1393-7.
2. Smith LDS, King EO. Occurrence o f Clostridium difficile in infections of
man. J Bacteriol 1962;84:65-7.
3. Simpson AJH, Das SS, Tabaqchali S. Nosocomial empyema caused by
Clostridium difficile. J Clin Pathol 1996;49:172-3.
4. Willis AT. Characteristics of the pathogenic and related clostridia. In: Willia
AT, ed. Anaerobic bacteriology: clinical and laboratory practice. Boston: 
Butterworths, 1977:111-66.
5. Gucalp R, Motyl M, Carlisle P, Dutcher J, Fuks J, Wiemik PH. Clostridium
cadaveris bacteremia in the immunocompromised host. Med Pediatr On­
col 1993;21:70-2.
6. Herman R, Goldman IS, Bronzo R, McKinley MJ. Clostridium cadaveris:
an unusual cause o f spontaneous bacterial peritonitis. Am J Gastroenterol 
1992;87:140-2.
